Quantcast

Latest Nephrology Stories

2014-07-18 12:00:52

American Society of Nephrology Living kidney donation rates dropping among low income populations in the US The decline in living kidney donation over the past several years has been concerning and is poorly understood. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) identifies low income as an important barrier to living donation, and more importantly, implies that this barrier is becoming more difficult to overcome over time. The...

2014-07-17 16:26:20

Analysis Shows Study Met Primary and All Secondary Endpoints THOUSAND OAKS, Calif., July 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a Phase 3 study evaluating AMG 416 (formerly known as velcalcetide) for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent reduction from...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-08 08:31:07

Special Guest Recording Artist and Former NxStage System One patient, David RUSH LAWRENCE, Mass., July 8, 2014 /PRNewswire/ -- WHAT: NxStage Kidney Care will be hosting a Grand Opening celebration and ribbon cutting reception for its new state-of-the- art dialysis center in Jacksonville, Florida. The Grand Opening event, which is open to the public, will include a ribbon cutting reception, tours of the 6,300 sq. ft. facility, and an opportunity to...

2014-07-04 23:02:00

Fresenius Medical Care North America Recalls 56 Lots of Liquid Bicarbonate Concentrate DALLAS (PRWEB) July 04, 2014 Fresenius Medical Care North America, manufacturer of the dialysis drugs GranuFlo and NaturaLyte, has recalled 56 lots of NaturaLyte due to finding higher bacteria levels than allowed by internal specifications. The company is involved in litigation in a Massachusetts federal court where more than 1,700 lawsuits have been filed in conjunction with a previous recall. (In Re:...

2014-07-03 16:23:16

WASHINGTON, July 3, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) expressed concern that a combination of flat payments and increased regulatory pressures proposed by the Centers for Medicare and Medicaid Services (CMS) may negatively impact stability and affect quality of care in Medicare's end-stage renal disease (ESRD) program. KCP is a coalition of patient advocates, clinicians, care professionals, dialysis providers, researchers, and manufacturers working together...

2014-07-03 12:25:51

NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day, NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, joins patients across the nation in celebrating the freedom and flexibility they have reclaimed with home hemodialysis (HHD) using the NxStage® System One(TM)....


Latest Nephrology Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.